These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6694870)

  • 1. Disseminated fungal infections in very low-birth-weight infants: therapeutic toxicity.
    Baley JE; Kliegman RM; Fanaroff AA
    Pediatrics; 1984 Feb; 73(2):153-7. PubMed ID: 6694870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic candidiasis in very low-birth-weight infants (less than 1,500 grams).
    Johnson DE; Thompson TR; Green TP; Ferrieri P
    Pediatrics; 1984 Feb; 73(2):138-43. PubMed ID: 6694869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal tolerance with the use of intralipid-amphotericin B in low-birth-weight neonates.
    Friedlich PS; Steinberg I; Fujitani A; deLemos RA
    Am J Perinatol; 1997 Aug; 14(7):377-83. PubMed ID: 9263555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated fungal infections in very low-birth-weight infants: clinical manifestations and epidemiology.
    Baley JE; Kliegman RM; Fanaroff AA
    Pediatrics; 1984 Feb; 73(2):144-52. PubMed ID: 6420764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal amphotericin B does not induce nephrotoxicity or renal function impairment in premature neonates.
    Manzoni P; Galletto P; Rizzollo S; Franco C; Gallo E; Antonucci R; Fanos V; Farina D
    Early Hum Dev; 2012 May; 88 Suppl 2():S86-91. PubMed ID: 22633524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fluid and electrolyte management on amphotericin B-induced nephrotoxicity among extremely low birth weight infants.
    Holler B; Omar SA; Farid MD; Patterson MJ
    Pediatrics; 2004 Jun; 113(6):e608-16. PubMed ID: 15173544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant.
    Michaels LA; Gurian M; Hegyi T; Drachtman RA
    Pediatrics; 2004 Sep; 114(3):703-7. PubMed ID: 15342842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early onset hyperkalemia in extremely low birth weight infants.
    Kilbride HW; Cater G; Warady BA
    J Perinatol; 1988; 8(3):211-4. PubMed ID: 3066873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotoxicity associated with amphotericin B deoxycholate in neonates.
    Le J; Adler-Shohet FC; Nguyen C; Lieberman JM
    Pediatr Infect Dis J; 2009 Dec; 28(12):1061-3. PubMed ID: 19935267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic treatment of systemic candidiasis in newborns.
    Serra G; Mezzano P; Bonacci W
    J Chemother; 1991 Jan; 3 Suppl 1():240-4. PubMed ID: 12041777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial].
    Rieger CT; Dittmer M; Ostermann H
    Dtsch Med Wochenschr; 2007 Oct; 132(40):2062-6. PubMed ID: 17899499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight.
    Frankenbusch K; Eifinger F; Kribs A; Rengelshauseu J; Roth B
    J Perinatol; 2006 Aug; 26(8):511-4. PubMed ID: 16871222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of antifungal therapy in an 800-gram infant with candidal arthritis and osteomyelitis.
    Ward RM; Sattler FR; Dalton AS
    Pediatrics; 1983 Aug; 72(2):234-8. PubMed ID: 6866610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants.
    Uko S; Soghier LM; Vega M; Marsh J; Reinersman GT; Herring L; Dave VA; Nafday S; Brion LP
    Pediatrics; 2006 Apr; 117(4):1243-52. PubMed ID: 16585321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes.
    Valverde E; Pellicer A; Madero R; Elorza D; Quero J; Cabañas F
    Pediatrics; 2006 Jun; 117(6):e1213-22. PubMed ID: 16717120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of sodium intake on Amphotericin B-induced nephrotoxicity among extremely premature infants.
    Turcu R; Patterson MJ; Omar S
    Pediatr Nephrol; 2009 Mar; 24(3):497-505. PubMed ID: 19082636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of vaccine coverage for low birth weight infants during the first year of life in a large managed care population.
    Batra JS; Eriksen EM; Zangwill KM; Lee M; Marcy SM; Ward JI;
    Pediatrics; 2009 Mar; 123(3):951-8. PubMed ID: 19255025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphotericin B deoxycholate (d-AMB) use in cases with febrile neutropenia and fungal infections: lower toxicity with suitable premedication.
    Oto OA; Paydas S; Disel U; Yavuz S; Seydaoglu G
    Mycoses; 2007 Mar; 50(2):135-9. PubMed ID: 17305778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which is the most appropriate dosage of liposomal Amphotericin-B (AmBisome) for the treatment of fungal infections in infants of very low birth weight?
    da Silva LP; Amaral JM; Ferreira NC
    Pediatrics; 1993 Jun; 91(6):1217-8. PubMed ID: 8502538
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
    Wingard JR
    Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.